Recent Insider Transactions - Astria Therapeutics (NASDAQ: ATXS)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ATXS Astria Therapeutics

Milne Jill C. / director, officer: CEO and President

03/21/2025

Buy

$6.41

761,000

$4.878M

761,000

NASDAQ ATXS Astria Therapeutics

Matthews Andrea / officer: Chief Business Officer

03/21/2025

Buy

$6.41

262,500

$1.683M

262,500

NASDAQ ATXS Astria Therapeutics

Komjathy Andrew / officer: Chief Commercial Officer

03/21/2025

Buy

$6.41

225,000

$1.442M

225,000

NASDAQ ATXS Astria Therapeutics

Harshbarger Benjamin / officer: Chief Legal Officer

03/21/2025

Buy

$6.41

262,500

$1.683M

262,500

NASDAQ ATXS Astria Therapeutics

Clauser Noah / officer: Chief Financial Officer

03/21/2025

Buy

$6.41

262,500

$1.683M

262,500

NASDAQ ATXS Astria Therapeutics

Morabito Christopher / officer: Chief Medical Officer

03/21/2025

Buy

$6.41

262,500

$1.683M

262,500